Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
COLLEGIUM PHARMACEUTICAL, INC | Director | Common Stock | 75.7K | $2.44M | $32.30 | May 16, 2024 | Direct |
COMPASS Pathways plc | Director | Share Option (Right to Buy) | 52K | Sep 3, 2024 | Direct | ||
Allena Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 37K | Jun 3, 2021 | Direct | ||
Horizon Therapeutics Public Ltd Co | Director | Ordinary Shares | 0 | $116.50 | Oct 6, 2023 | By Trust | |
Horizon Therapeutics Public Ltd Co | Director | Ordinary Shares | 0 | $116.50 | Oct 6, 2023 | Direct | |
Horizon Therapeutics Public Ltd Co | Director | Restricted Stock Units | 0 | Oct 6, 2023 | Direct | ||
Horizon Therapeutics Public Ltd Co | Director | Stock Option (Right to Buy) | 0 | Oct 6, 2023 | Direct | ||
INTERCEPT PHARMACEUTICALS, INC. | Director | Common Stock | 0 | $19.00 | Nov 8, 2023 | Direct | |
INTERCEPT PHARMACEUTICALS, INC. | Director | Option to Purchase Common Stock | 0 | Nov 8, 2023 | Direct |